Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

99
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
99
Vaccinations01:51

Vaccinations

54.7K
Overview
54.7K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Vaccines01:21

Vaccines

62
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
62
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma.

Drug design, development and therapy·2026
Same author

Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016-2024).

Translational and clinical pharmacology·2026
Same author

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Teicoplanin in Korean Neutropenic Hematopoietic Stem Cell Transplant Recipients.

Drug design, development and therapy·2026
Same author

Quantification of Total and Unbound Selinexor Concentrations in Human Plasma by a Fully Validated Liquid Chromatography-Tandem Mass Spectrometry Method.

Pharmaceutics·2025
Same author

Correction: Participant Adherence in Repeated-Dose Clinical Studies Using Video-Based Observation: Retrospective Data Analysis.

JMIR mHealth and uHealth·2025
Same author

Participant Adherence in Repeated-Dose Clinical Studies Using Video-Based Observation: Retrospective Data Analysis.

JMIR mHealth and uHealth·2025
Same journal

Determinants of HPV vaccine hesitancy in South Asia: a systematic review.

Clinical and experimental vaccine research·2026
Same journal

Vaccine development against <i>Mycobacterium tuberculosis</i>: a PRISMA-guided systematic review of conventional and computational multi-epitope approaches.

Clinical and experimental vaccine research·2026
Same journal

Pharmaceutical design of mRNA vaccines for endemic infectious diseases: integrating antigen discovery with platform engineering.

Clinical and experimental vaccine research·2026
Same journal

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.

Clinical and experimental vaccine research·2026
Same journal

Varicella zoster virus infection and reactivation in a psychiatric ward during the COVID-19 pandemic: a case series analysis.

Clinical and experimental vaccine research·2026
Same journal

Survival after primary and booster COVID-19 vaccination in patients with COPD.

Clinical and experimental vaccine research·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Clinical vaccine development.

Seunghoon Han1

  • 1Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea. ; Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Clinical and Experimental Vaccine Research
|February 5, 2015
PubMed
Summary
This summary is machine-generated.

Vaccine development is advancing rapidly, offering protection against infectious diseases and cancers. Ongoing research aims to improve vaccine effectiveness and safety for better public health outcomes.

Keywords:
Clinical trialHistoryVaccinationVaccines

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.2K

Related Experiment Videos

Last Updated: Apr 17, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.2K

Area of Science:

  • * Medicine and Public Health
  • * Immunology and Microbiology
  • * Biotechnology

Background:

  • * Vaccination represents a monumental achievement in medical history, with current vaccine development being highly successful.
  • * Significant advancements in knowledge and funding have facilitated vaccine creation for infectious diseases and malignant tumors.
  • * Clinical evaluation and licensure processes for vaccines have been updated based on scientific progress and past experiences.

Purpose of the Study:

  • * To highlight the current era of unprecedented vaccine development success.
  • * To underscore the importance of understanding recent trends in vaccination and associated diseases.
  • * To emphasize the need for continuous improvement in vaccine efficacy and safety.

Main Methods:

  • * Review of multidisciplinary knowledge in immunology and microbiology.
  • * Analysis of historical data and scientific improvements in vaccine evaluation.
  • * Focus on translating cutting-edge research into practical vaccine development.

Main Results:

  • * Development of vaccines for a wide range of diseases, including cancers.
  • * Modernization of vaccine evaluation and licensure paradigms.
  • * Ongoing efforts to enhance vaccine efficacy and minimize risks.

Conclusions:

  • * The field of vaccinology is experiencing a period of rapid innovation and success.
  • * Addressing remaining challenges in efficacy and safety is crucial.
  • * Clinicians and researchers must stay informed about evolving vaccine technologies and disease targets.